Disease-free survival | ||||||
---|---|---|---|---|---|---|
Univariate | Multivariate | |||||
HR | 95 % CI | P value | HR | 95 % CI | P value | |
Sex | ||||||
Male/female | 1.70 | 1.08–2.69 | 0.023 | 1.37 | 0.85–2.19 | 0.187 |
Age | ||||||
>70/≦70 | 2.42 | 1.58–3.71 | <0.001 | 1.94 | 1.24–3.04 | 0.004 |
Tumor size | ||||||
T2–3/T1 | 2.25 | 1.47–3.45 | <0.001 | 1.14 | 0.74–1.76 | 0.560 |
Nodal metastasis | ||||||
Positive/negative | 6.50 | 4.30–9.80 | <0.001 | 6.42 | 4.16–9.89 | <0.001 |
Histological type | ||||||
AD/non-AD | 1.45 | 0.95–2.20 | 0.083 | 0.72 | 0.46–1.13 | 0.150 |
Tumor differentiation | ||||||
Mod+por/well | 2.71 | 1.65–4.44 | <0.001 | 1.69 | 1.01–2.83 | 0.047 |
NLR | ||||||
≥2.5/<2.5 | 2.09 | 1.40–3.12 | <0.001 | 1.58 | 1.02–2.43 | 0.039 |
PNI | ||||||
<50/≥50 | 2.28 | 1.52–3.42 | <0.001 | 1.88 | 1.19–2.97 | 0.007 |
Overall survival | ||||||
Sex | ||||||
Male/female | 1.76 | 1.04–2.97 | 0.035 | 1.19 | 0.67–2.10 | 0.554 |
Age | ||||||
>70/≦70 | 3.54 | 2.07–6.05 | <0.001 | 2.31 | 1.30–4.08 | 0.004 |
Tumor size | ||||||
T2-3/T1 | 2.60 | 1.56–4.31 | <0.001 | 1.45 | 0.85–2.46 | 0.171 |
Nodal metastasis | ||||||
Positive/negative | 4.21 | 2.62-6.74 | <0.001 | 3.78 | 2.34–6.13 | <0.001 |
Histological type | ||||||
AD/non-AD | 1.20 | 1.05–1.36 | 0.006 | 1.07 | 0.92–1.24 | 0.373 |
Tumor differentiation | ||||||
Mod+por/well | 2.81 | 1.59–4.99 | <0.001 | 1.60 | 0.85–3.02 | 0.143 |
NLR | ||||||
≥2.5/<2.5 | 1.81 | 1.14–2.87 | 0.012 | 1.60 | 1.04–2.54 | 0.048 |
PNI | ||||||
<50/≥50 | 3.37 | 2.07–5.48 | <0.001 | 2.40 | 1.39–4.14 | 0.002 |